Publication | Closed Access

Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma

Surgical OncologyPhase Ii TrialRadiation TherapyGastrointestinal OncologyConcurrent Irinotecan–cisplatinMedicineGastroenterologySurgeryEsophagogastric Junction AdenocarcinomaOncologyRadiation Oncology